Mastery EAQ Ch. 10

A  Narcotic analgesics should not be used for more than 24 hours.

B  Analgesics should be administered as needed to minimize adverse effects.

C  Patients should request analgesics when the pain level reaches a 3 on a scale of 1 to 10.

D  Pain relief is best obtained by administering analgesics around the clock.

A  Slow pupil reaction, Excess urination, Change in sputum color

B  Hallucinations, Slow pupil reaction, Altered consciousness

C  Excess urination, Hallucinations, Change in sputum color

D  Altered consciousness, Excess urination, Change in sputum color

A  Placed on the same place as the old patch

B  Placed on a new area, with the old patch still in place

C  Placed on a hairy area

D  Placed on an area after cleaning it

A  Administer a short-acting opioid and follow the regular opioid schedule for the next dose.

B  Distract the patient for 2 hours by using alternative methods, such as music therapy.

C  Administer the scheduled opioid dose early.

D  Ask the patient to bear the pain until the next scheduled opioid dose.

A  “Increase the dose of morphine if there is no relief of pain.”
“Rest before taking the medication.”

B  “Drink at least 3 liters of fluid a day.”
“Take an over-the-counter stool softener daily.”

C  “Rest before taking the medication.”
“Take acetaminophen with the morphine.”

D  “Increase the dose of morphine if there is no relief of pain.”
“Take acetaminophen with the morphine.”

A  Prepare for intubation.

B  Call the respiratory team stat.

C  Assess arterial blood gases.

D  Administer naloxone.

A  Hyperactive bowel sounds

B  Sedation

C  Diarrhea

D  Insomnia

A  “Take the medication frequently.”
“Swallow the medication whole.”
“Increase the dose if you experience no pain relief.”

B  “Take the medication frequently.”
“Increase the dose if you experience no pain relief.”
“Do not crush the medication.”

C  “Do not dissolve the medication in water.”
“Take the medication frequently.”
“Increase the dose if you experience no pain relief.”

D  “Do not crush the medication.”
“Swallow the medication whole.”
“Do not dissolve the medication in water.”

A  Asthma

B  Cancer

C  Diarrhea

D  Anorexia

A  Assess the patient’s neurologic status.

B  Reassess the patient in an hour.

C  Administer a narcotic antagonist.

D  Assess blood gases.

A  Hemoglobin 11.2 g/dL

B  Serum creatinine 0.8 mg/dL

C  Serum bilirubin 3.2 mg/dL

D  Random blood glucose 140 mg/dL

A  Administer 1 mg of morphine and notify the primary health care provider.

B  Administer another 1 mg of morphine and reevaluate the pain scale in 15 minutes.

C  Hold the drug, record the assessment, and reassess the patient in 1 hour.

D  Consult the primary health care provider and obtain another drug prescription.

A  Acetylcysteine

B  Methylprednisolone

C  Naloxone

D  Protamine sulfate

A  Withhold the scheduled opioid dose.

B  Inform the primary health care provider.

C  Administer the scheduled opioid dose.

D  Administer an opioid antagonist.

A  “Tell me more about your understanding of how epidural analgesia relieves your pain.”

B  “If you don’t turn, cough, and breathe deeply, you may get pneumonia or other complications.”

C  “There’s no needle. It’s a thin plastic tube in the protective covering of your spinal cord.”

D  “I can understand your fears, but there is no risk of paralysis from epidural analgesia.”

A  Acetylcysteine

B  Nalbuphine

C  Naloxone

D  Naltrexone hydrochloride

A  Within a half hour

B  Within 2 hours

C  In 8 hours

D  In 4 hours

A  Blood in urine

B  Heart rate 110 beats/min

C  Respiratory rate 28 breaths/min

D  Pinpoint pupils

A  Initiate resuscitative measures.

B  Prepare intravenous naloxone.

C  Administer flumazenil.

D  Assess the patients’ responsiveness.

A  Cough reflex

B  Chemoreceptor trigger zone

C  Circulation

D  Respiratory rate

A  No bowel movement in 72 hours

B  Vague feeling of anxiety

C  Respiratory rate 12 breaths/min

D  Heart rate 90 beats/min

A  Administer naltrexone hydrochloride.

B  Assess the patient for pain.

C  Administer an amphetamine.

D  Assess the patient’s electrocardiogram (ECG).

A  Assessment of chronic diseases causing pain

B  Questions regarding past history of drug and alcohol use

C  Questions regarding the date of the last flu vaccine

D  Assessment of culture reports

A  Skin rashes, Blurred vision, Nausea

B  Skin rashes, Muscle stiffness, Blurred vision

C  Joint pain, Skin rashes, Blurred vision

D  Nausea, Joint pain, Muscle stiffness

A  “Dispose of patches by melting them with a flame.”

B  “Store the patches in the bathroom medicine cabinet.”

C  “Apply heat over the patch to increase absorption.”

D  “Keep new and used patches away from children.”

A  Binds in place of the agonist and causes no response

B  Binds and causes less pain response than an agonist

C  Binds instead of the agonist and causes analgesia

D  Binds and causes a response opposite to that of an agonist

A  107 mg

B  125 mg

C  150 mg

D  100 mg

A  Deep pain

B  Superficial pain

C  Somatic pain

D  Visceral pain

A  Constipation

B  Dizziness

C  Miosis

D  Diarrhea

A  “This medication will help you get rid of mucous.”

B  “This medication is used as a cough suppressant.”

C  “This medication helps open up your airways.”

D  “This medication will help your immune system.”

A  “Your pain is well controlled now. Why are you so worried?”

B  “Tell me more about your fears.”

C  “The disability benefit of your insurance plan will help pay your bills.”

D  “Everything will be fine. You will be back to work in about 6 weeks.”

A  Respiratory rate

B  Heart rate

C  Mental status

D  Blood pressure

A  Mucosal irritation

B  Constipation

C  Crystalluria

D  Electrolyte imbalance

A  Blurred vision, Vomiting, Decreased hearing

B  Blurred vision, Decreased hearing, Elevated liver enzymes

C  Nausea, Blurred vision, Decreased hearing

D  Nausea, Vomiting, Elevated liver enzymes

A  Call the primary health care provider.

B  Administer naloxone.

C  Add a second patch.

D  Change the patch.

A  1 mg

B  0.5 mg

C  0.4 mg

D  0.8 mg

A  Blood urea nitrogen (BUN) and creatinine levels

B  Aspartate transaminase (AST) and alanine transaminase (ALT) levels

C  Platelet count

D  Neutrophil count

A  Anemia

B  Severe liver disease

C  Joint pain

D  Asthma

A  Somatic pain

B  Superficial pain

C  Visceral pain

D  Deep pain

A  Severe pain resulting from cancer metastasis

B  Pain after abdominal surgery

C  Acute migraine

D  Lower back pain related to lumbar strain

A  Fentanyl

B  Hydromorphone

C  Codeine sulfate

D  Meperidine

A  Persistent

B  Sympathetic nervous system response

C  Sudden onset

D  Sharp

A  Methylprednisolone

B  Naloxone

C  Acetylcysteine

D  Flumazenil

A  To induce a state of unconsciousness

B  To treat ischemic pain

C  To diminish feelings of anxiety

D  To relieve acute and chronic pain

A  Phantom pain

B  Vascular pain

C  Referred pain

D  Neuropathic pain